Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03360370

Neurodevelopmental Disorders in Children With Congenital Heart Disease

Sponsor: University Hospital, Lille

View on ClinicalTrials.gov

Summary

Children with congenital heart disease are at risk for neurodevelopmental disorders, these disorders impacting their quality of life and their integration into society. The aim of this study is to detect neurodevelopmental disorders in children (aged from 6 to 66 months) with congenital heart disease in Nord-Pas-De-Calais (France) and to evaluate the frequency and risk factors of these neurodevelopmental disorders for a better follow-up. This study will help implementing a specific program for the evaluation and management of neurodevelopmental disorders in children suffering from congenital heart disease in Nord-Pas-De-Calais and more globally, in the region Hauts-De-France.

Official title: Screening for Neurodevelopmental Disorders in Children With Congenital Heart Disease Aged From 6 to 66 Months in Nord-Pas-de-Calais

Key Details

Gender

All

Age Range

6 Months - 66 Months

Study Type

OBSERVATIONAL

Enrollment

233

Start Date

2017-12-06

Completion Date

2018-06-06

Last Updated

2026-05-14

Healthy Volunteers

No

Interventions

OTHER

Ages & Stages Questionnaires, Third Edition in French (ASQ-3™)

This questionnaire screens 5 neurodevelopmental areas (communication, gross motor, fine motor, problem solving and personal-social); 30 items per questionnaire about the child's abilities are evaluated. It takes about 15-20 minutes. Data are collecting and a scoring by a professional is provided. Follow-up action is taken for children at risk. Medical and surgical history is also collected to detect risk factors for neurodevelopmental disorders among neonatal data, characteristics of congenital heart disease and first surgery, and other comorbidities.

Locations (1)

Hôpital Jeanne de Flandres, CHU

Lille, France